Home » Topics » Regulatory

Regulatory
RSS

FDA clears new Allegra product; Seldane to be withdrawn

Jan. 7, 1998

Faulding establishes new U.S. division, regains rights to Kadian

Jan. 7, 1998

NDA filed for extended-release Ditropan formulation

Dec. 29, 1997

Alferon evaluated in patients coinfected with HIV and HCV

Dec. 29, 1997

FDA approval obtained for Prandin

Dec. 29, 1997

TOBI approved by FDA for management of CF patients

Dec. 29, 1997

FDA clears new oral treatment for hair loss in men

Dec. 29, 1997

Chiron's Proleukin recommended for approval for new indication

Dec. 23, 1997

FDA clears Trovan, Pfizer's broad-spectrum quinolone

Dec. 22, 1997

Nutropin AQ also wins FDA approval

Dec. 19, 1997

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
News in brief
BioWorld Asia
BioWorld Asia briefs for Feb. 10, 2026